Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Garrett Gross
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Chemicals & Drugs
Physiology
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
39
Warltier, David
37
Hsu, Anna
31
Pieper, Galen
21
Peart, Jason
21
Gross, Eric
18
Nithipatikom, Kasem
17
Fryer, Ryan
16
Baker, John
15
Patel, Hemal
14
Farber, Neil
12
Gumina, Richard
10
Falck, John
10
Auchampach, John
10
Hsu, Anna
10
Mei, David
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Garrett Gross (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Gross Eric R; Hsu Anna K; Gross Garrett J
Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.
Anesthesia and analgesia 2009;109(5):1395-402.
-
2009: Gross Garrett J; Gauthier Kathryn M; Moore Jeannine; Campbell William B; Falck John R; Nithipatikom Kasem
Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog.
American journal of physiology. Heart and circulatory physiology 2009;297(1):H47-52.
-
2009: Gross Garrett J; Nithipatikom Kasem
Soluble epoxide hydrolase: a new target for cardioprotection.
Current opinion in investigational drugs (London, England : 2000) 2009;10(3):253-8.
-
2008: Peart Jason N; Gross Eric R; Reichelt Melissa E; Hsu Anna; Headrick John P; Gross Garrett J
Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
Basic research in cardiology 2008;103(5):454-63.
-
2008: Purdham Daniel M; Rajapurohitam Venkatesh; Zeidan Asad; Huang Cathy; Gross Garrett J; Karmazyn Morris
A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart.
American journal of physiology. Heart and circulatory physiology 2008;295(1):H441-6.
-
2008: Gross Garrett J; Gauthier Kathryn M; Moore Jeannine; Falck John R; Hammock Bruce D; Campbell William B; Nithipatikom Kasem
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
American journal of physiology. Heart and circulatory physiology 2008;294(6):H2838-44.
-
2008: Gross Eric R; Hsu Anna K; Gross Garrett J
Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion.
American journal of physiology. Heart and circulatory physiology 2008;294(3):H1497-500.
-
2008: Strande Jennifer L; Hsu Anna; Su Jidong; Fu Xiangping; Gross Garrett J; Baker John E
Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling.
The Journal of pharmacology and experimental therapeutics 2008;324(3):1045-54.
-
2008: Nicolosi Alfred C; Strande Jennifer L; Hsu Anna; Fu Xiangping; Su Jidong; Gross Garrett J; Baker John E
Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms.
Journal of molecular and cellular cardiology 2008;44(2):345-51.
-
2008: Dhanasekaran Anuradha; Gruenloh Stephanie K; Buonaccorsi J Noelle; Zhang Rong; Gross Garrett J; Falck John R; Patel Paresh K; Jacobs Elizabeth R; Medhora Meetha
Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia.
American journal of physiology. Heart and circulatory physiology 2008;294(2):H724-35.
-
2008: Baker John E; Su Jidong; Hsu Anna; Shi Yang; Zhao Ming; Strande Jennifer L; Fu Xiangping; Xu Hao; Eis Annie; Komorowski Richard; Jensen Eric S; Tweddell James S; Rafiee Parvaneh; Gross Garrett J
Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats.
Cardiovascular research 2008;77(1):44-53.
-
2008: Wan Tina C; Ge Zhi-Dong; Tampo Akihito; Mio Yasushi; Bienengraeber Martin W; Tracey W Ross; Gross Garrett J; Kwok Wai-Meng; Auchampach John A
The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
The Journal of pharmacology and experimental therapeutics 2008;324(1):234-43.
-
2007: Gauthier Kathryn M; Yang Wenqi; Gross Garrett J; Campbell William B
Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning.
Journal of cardiovascular pharmacology 2007;50(6):601-8.
-
2007: Baker John E; Su Jidong; Fu Xiangping; Hsu Anna; Gross Garrett J; Tweddell James S; Hogg Neil
Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels.
Journal of molecular and cellular cardiology 2007;43(4):437-44.
-
2007: Bolte Craig S; Liao Siyun; Gross Garrett J; Schultz Jo El J
Remote preconditioning-endocrine factors in organ protection against ischemic injury.
Endocrine, metabolic & immune disorders drug targets 2007;7(3):167-75.
-
2007: Gross Eric R; Gross Garrett J
Pharmacologic therapeutics for cardiac reperfusion injury.
Expert opinion on emerging drugs 2007;12(3):367-88.
-
2007: Strande Jennifer L; Hsu Anna; Su Jidong; Fu Xiangping; Gross Garrett J; Baker John E
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Basic research in cardiology 2007;102(4):350-8.
-
2007: Gross Eric R; Hsu Anna K; Gross Garrett J
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
Basic research in cardiology 2007;102(4):341-9.
-
2007: Baker John E; Kozik Deborah; Hsu Anna K; Fu Xiangping; Tweddell James S; Gross Garrett J
Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
Journal of cardiovascular pharmacology 2007;49(6):337-45.
-
2007: Peart Jason N; Gross Eric R; Headrick John P; Gross Garretta J
Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.
Journal of molecular and cellular cardiology 2007;42(5):972-80.
-
2007: Gross G J; Peart J N
Opioids and myocardial reperfusion injury.
Archives des maladies du coeur et des vaisseaux 2007;100(3):231-7.
-
2007: Gross Garrett J; Hsu Anna; Falck John R; Nithipatikom Kasem
Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.
Journal of molecular and cellular cardiology 2007;42(3):687-91.
-
2007: Gross Eric R; Hsu Anna K; Gross Garrett J
Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta.
Diabetes 2007;56(1):127-36.
-
2007: Seubert John M; Zeldin Darryl C; Nithipatikom Kasem; Gross Garrett J
Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.
Prostaglandins & other lipid mediators 2007;82(1-4):50-9.
-
2007: Gross Garrett J; Auchampach John A
Reperfusion injury: does it exist?
Journal of molecular and cellular cardiology 2007;42(1):12-8.
-
2006: Ge Zhi-Dong; Peart Jason N; Kreckler Laura M; Wan Tina C; Jacobson Marlene A; Gross Garrett J; Auchampach John A
Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
The Journal of pharmacology and experimental therapeutics 2006;319(3):1200-10.
-
2006: Lockwood Samuel F; Jackson Henry L; Gross Garrett J
Retrometabolic syntheses of astaxanthin (3,3'-dihydroxy-beta,beta-carotene-4,4'-dione) conjugates: a novel approach to oral and parenteral cardio-protection.
Cardiovascular & hematological agents in medicinal chemistry 2006;4(4):335-49.
-
2006: Peart Jason N; Gross Garrett J
Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways.
American journal of physiology. Heart and circulatory physiology 2006;291(4):H1746-53.
-
2006: Gross Eric R; Hsu Anna K; Gross Garrett J
The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta.
American journal of physiology. Heart and circulatory physiology 2006;291(2):H827-34.
-
2006: Nithipatikom Kasem; Moore Jeannine M; Isbell Marilyn A; Falck John R; Gross Garrett J
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
American journal of physiology. Heart and circulatory physiology 2006;291(2):H537-42.
-
2006: Patel Hemal H; Head Brian P; Petersen Heidi N; Niesman Ingrid R; Huang Diane; Gross Garrett J; Insel Paul A; Roth David M
Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors.
American journal of physiology. Heart and circulatory physiology 2006;291(1):H344-50.
-
2006: Gross Eric R; Gross Garrett J
Ligand triggers of classical preconditioning and postconditioning.
Cardiovascular research 2006;70(2):212-21.
-
2006: Gross Garrett J; Hazen Stanley L; Lockwood Samuel F
Seven day oral supplementation with Cardax (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats.
Molecular and cellular biochemistry 2006;283(1-2):23-30.
-
2006: Nithipatikom Kasem; Endsley Michael P; Moore Jeannine M; Isbell Marilyn A; Falck John R; Campbell William B; Gross Garrett J
Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection.
American journal of physiology. Heart and circulatory physiology 2006;290(2):H500-5.
-
2006: Watson Michael J; Holt Jonathon D S; O'Neill Scott J; Wei Ke; Pendergast William; Gross Garrett J; Gengo Peter J; Chang Kwen-Jen
ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
The Journal of pharmacology and experimental therapeutics 2006;316(1):423-30.
-
2005: Gross Garrett J
Remote preconditioning and delayed cardioprotection in skeletal muscle.
American journal of physiology. Regulatory, integrative and comparative physiology 2005;289(6):R1562-3.
-
2005: Gumina Richard J; El Schultz Jo; Moore Jeanine; Beier Norbert; Schelling Pierre; Gross Garrett J
Cardioprotective-mimetics reduce myocardial infarct size in animals resistant to ischemic preconditioning.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(5):315-22.
-
2005: Gross Garrett J; Falck John R; Gross Eric R; Isbell Marilyn; Moore Jeannine; Nithipatikom Kasem
Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
Cardiovascular research 2005;68(1):18-25.
-
2005: Lubbers Nathan L; Campbell Thomas J; Polakowski James S; Bulaj Grzegorz; Layer Richard T; Moore Jeannine; Gross Garrett J; Cox Bryan F
Postischemic administration of CGX-1051, a peptide from cone snail venom, reduces infarct size in both rat and dog models of myocardial ischemia and reperfusion.
Journal of cardiovascular pharmacology 2005;46(2):141-6.
-
2005: Peart J N; Gross G J
Cardioprotection following adenosine kinase inhibition in rat hearts.
Basic research in cardiology 2005;100(4):328-36.
-
2005: Gross Eric R; Peart Jason N; Hsu Anna K; Auchampach John A; Gross Garrett J
Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway.
American journal of physiology. Heart and circulatory physiology 2005;288(6):H2744-9.
-
2005: Peart Jason N; Gross Garrett J
Cross-talk between adenosine and opioid receptors.
Drug news & perspectives 2005;18(4):237-42.
-
2005: Gross Garrett J; Lockwood Samuel F
Acute and chronic administration of disodium disuccinate astaxanthin (Cardax) produces marked cardioprotection in dog hearts.
Molecular and cellular biochemistry 2005;272(1-2):221-7.
-
2005: Peart Jason N; Gross Eric R; Gross Garrett J
Opioid-induced preconditioning: recent advances and future perspectives.
Vascular pharmacology 2005;42(5-6):211-8.
-
2005: Gross Garrett J
Pharmacological preconditioning: Potential new treatment modalities for the ischemic myocardium.
Vascular pharmacology 2005;42(5-6):199.
-
2005: Gross Garrett J
Sildenafil and endothelial dysfunction in humans.
Circulation 2005;111(6):721-3.
-
2005: Gross Garrett J
Mitochondrial ATP-sensitive potassium channels and myocardial hypertrophy.
Journal of molecular and cellular cardiology 2005;38(2):237-9.
-
2005: Patel Hemal H; Gross Eric R; Peart Jason N; Hsu Anna K; Gross Garrett J
Sarcolemmal KATP channel triggers delayed ischemic preconditioning in rats.
American journal of physiology. Heart and circulatory physiology 2005;288(1):H445-7.
-
2005: Fitzpatrick Colleen M; Shi Yang; Hutchins William C; Su Jidong; Gross Garrett J; Ostadal Bohuslav; Tweddell James S; Baker John E
Cardioprotection in chronically hypoxic rabbits persists on exposure to normoxia: role of NOS and KATP channels.
American journal of physiology. Heart and circulatory physiology 2005;288(1):H62-8.
-
2005: Lockwood Samuel F; Gross Garrett J
Disodium disuccinate astaxanthin (Cardax): antioxidant and antiinflammatory cardioprotection.
Cardiovascular drug reviews 2005;23(3):199-216.
-
2004: Gross Eric R; Nithipatikom Kasem; Hsu Anna K; Peart Jason N; Falck John R; Campbell William B; Gross Garrett J
Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel.
Journal of molecular and cellular cardiology 2004;37(6):1245-9.
-
2004: Nithipatikom Kasem; Gross Eric R; Endsley Michael P; Moore Jeannine M; Isbell Marilyn A; Falck John R; Campbell William B; Gross Garrett J
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
Circulation research 2004;95(8):e65-71.
-
2004: Peart Jason N; Gross Garrett J
Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts.
Experimental gerontology 2004;39(7):1021-6.
-
2004: Gross Garrett J; Moore Jeannine
Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine.
Pharmacology 2004;71(3):135-42.
-
2004: Gross Eric R; Hsu Anna K; Gross Garrett J
Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenase.
The Journal of pharmacology and experimental therapeutics 2004;310(1):185-91.
-
2004: Gross Garrett J; Lockwood Samuel F
Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax).
Life sciences 2004;75(2):215-24.
-
2004: Patel Hemal H; Hsu Anna K; Gross Garrett J
COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Life sciences 2004;75(2):129-40.
-
2004: Gross Eric R; Hsu Anna K; Gross Garrett J
Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
Circulation research 2004;94(7):960-6.
-
2004: Peart Jason N; Gross Eric R; Gross Garrett J
Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction.
Journal of cardiovascular pharmacology 2004;43(3):410-5.
-
2004: Peart Jason N; Gross Garrett J
Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype.
Circulation 2004;109(10):1219-22.
-
2004: Auchampach John A; Jin Xiaowei; Moore Jeannine; Wan Tina C; Kreckler Laura M; Ge Zhi-Dong; Narayanan Jayashree; Whalley Eric; Kiesman William; Ticho Barry; Smits Glenn; Gross Garrett J
Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs.
The Journal of pharmacology and experimental therapeutics 2004;308(3):846-56.
-
2004: Patel Hemal H; Hsu Anna; Gross Garrett J
Delayed cardioprotection is mediated via a non-peptide delta opioid agonist, SNC-121, independent of opioid receptor stimulation.
Basic research in cardiology 2004;99(1):38-45.
-
2004: Peart Jason N; Gross Garrett J
Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart.
Basic research in cardiology 2004;99(1):29-37.
-
2004: Muthian S; Rademacher D J; Roelke C T; Gross G J; Hillard C J
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.
Neuroscience 2004;129(3):743-50.
-
2003: Gross Garrett J
Selective ATP-sensitive potassium channel openers: fact or fiction.
Journal of molecular and cellular cardiology 2003;35(9):1005-7.
-
2003: Gross Garrett J; Peart Jason N
KATP channels and myocardial preconditioning: an update.
American journal of physiology. Heart and circulatory physiology 2003;285(3):H921-30.
-
2003: Gross Eric R; Peart Jason N; Hsu Anna K; Grover Gary J; Gross Garrett J
K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2.
Journal of molecular and cellular cardiology 2003;35(8):985-92.
-
2003: Auchampach John A; Ge Zhe-Dong; Wan Tina C; Moore Jeannine; Gross Garrett J
A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
American journal of physiology. Heart and circulatory physiology 2003;285(2):H607-13.
-
2003: Peart Jason N; Patel Hemal H; Gross Garrett J
Delta-opioid receptor activation mimics ischemic preconditioning in the canine heart.
Journal of cardiovascular pharmacology 2003;42(1):78-81.
-
2003: Gross Garrett J
Role of opioids in acute and delayed preconditioning.
Journal of molecular and cellular cardiology 2003;35(7):709-18.
-
2003: Peart Jason N; Gross Garrett J
Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors.
American journal of physiology. Heart and circulatory physiology 2003;285(1):H81-9.
-
2003: Patel Hemal H; Fryer Ryan M; Gross Eric R; Bundey Richard A; Hsu Anna K; Isbell Marilyn; Eusebi Leonard O V; Jensen Roderick V; Gullans Steven R; Insel Paul A; Nithipatikom Kasem; Gross Garrett J
12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses.
Circulation research 2003;92(6):676-82.
-
2003: Ludwig Lynda M; Patel Hemal H; Gross Garrett J; Kersten Judy R; Pagel Paul S; Warltier David C
Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors.
Anesthesiology 2003;98(3):705-11.
-
2003: Ge Zhi-Dong; Auchampach John A; Piper Galen M; Gross Garrett J
Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists.
Journal of cardiovascular pharmacology 2003;41(3):481-8.
-
2002: Gross Garrett J
The role of mitochondrial K(ATP) channels in the antiarrhythmic effects of ischaemic preconditioning in dogs.
British journal of pharmacology 2002;137(7):939-40.
-
2002: Peart J N; Gross G J
Sarcolemmal and mitochondrial K(ATP) channels and myocardial ischemic preconditioning.
Journal of cellular and molecular medicine 2002;6(4):453-64.
-
2002: Patel Hemal H; Moore Jeannine; Hsu Anna K; Gross Garrett J
Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism.
Journal of molecular and cellular cardiology 2002;34(10):1317-23.
-
2002: Patel Hemal H; Ludwig Lynda M; Fryer Ryan M; Hsu Anna K; Warltier David C; Gross Garrett J
Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K(ATP) channel opening.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(11):1468-70.
-
2002: Patel Hemal H; Hsu Anna K; Peart Jason N; Gross Garrett J
Sarcolemmal K(ATP) channel triggers opioid-induced delayed cardioprotection in the rat.
Circulation research 2002;91(3):186-8.
-
2002: Fryer Ryan M; Auchampach John A; Gross Garrett J
Therapeutic receptor targets of ischemic preconditioning.
Cardiovascular research 2002;55(3):520-5.
-
2002: Warltier David C; Kersten Judy R; Pagel Paul S; Gross Garrett J
Editorial view: anesthetic preconditioning: serendipity and science.
Anesthesiology 2002;97(1):1-3.
-
2002: Ge Zhi-Dong; Li Pin-Lan; Chen Ya-Fei; Gross Garrett J; Zou Ai-Ping
Myocardial ischemia and reperfusion reduce the levels of cyclic ADP-ribose in rat myocardium.
Basic research in cardiology 2002;97(4):312-9.
-
2002: Tonkovic-Capin Marija; Gross Garrett J; Bosnjak Zeljko J; Tweddell James S; Fitzpatrick Colleen M; Baker John E
Delayed cardioprotection by isoflurane: role of K(ATP) channels.
American journal of physiology. Heart and circulatory physiology 2002;283(1):H61-8.
-
2002: Patel Hemal H; Hsu Anna; Gross Garrett J
Attenuation of heat shock-induced cardioprotection by treatment with the opiate receptor antagonist naloxone.
American journal of physiology. Heart and circulatory physiology 2002;282(6):H2011-7.
-
2002: Gross Garrett J; Warltier David C
Prologue: nonclassical modalities of myocardial preconditioning.
American journal of physiology. Heart and circulatory physiology 2002;282(6):H1951-2.
-
2002: Fryer Ryan M; Hsu Anna K; Wang Yigang; Henry Michele; Eells Janis; Gross Garrett J
PKC-delta inhibition does not block preconditioning-induced preservation in mitochondrial ATP synthesis and infarct size reduction in rats.
Basic research in cardiology 2002;97(1):47-54.
-
2002: Patel Hemal H; Gross Garrett J
The disputed role of COX-2 in myocardial infarction, is the jury still out?
Journal of molecular and cellular cardiology 2002;34(1):1-3.
-
2001: Zhang D X; Chen Y F; Campbell W B; Zou A P; Gross G J; Li P L
Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels.
Circulation research 2001;89(12):1177-83.
-
2001: An J; Varadarajan S G; Camara A; Chen Q; Novalija E; Gross G J; Stowe D F
Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts.
American journal of physiology. Heart and circulatory physiology 2001;281(6):H2398-409.
-
2001: Fryer R M; Wang Y; Hsu A K; Nagase H; Gross G J
Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway.
The Journal of pharmacology and experimental therapeutics 2001;299(2):477-82.
-
2001: Gumina R J; Moore J; Schelling P; Beier N; Gross G J
Na(+)/H(+) exchange inhibition prevents endothelial dysfunction after I/R injury.
American journal of physiology. Heart and circulatory physiology 2001;281(3):H1260-6.
-
2001: Fryer R M; Patel H H; Hsu A K; Gross G J
Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium.
American journal of physiology. Heart and circulatory physiology 2001;281(3):H1184-92.
-
2001: Patel H H; Hsu A; Moore J; Gross G J
BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation.
Journal of molecular and cellular cardiology 2001;33(8):1455-65.
-
2001: Gumina R J; Terzic A; Gross G J
Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism?
Basic research in cardiology 2001;96(4):318-24.
-
2001: Zhang D X; Fryer R M; Hsu A K; Zou A P; Gross G J; Campbell W B; Li P L
Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats.
Basic research in cardiology 2001;96(3):267-74.
-
2001: Kong X; Tweddell J S; Gross G J; Baker J E
Sarcolemmal and mitochondrial K(atp)channels mediate cardioprotection in chronically hypoxic hearts.
Journal of molecular and cellular cardiology 2001;33(5):1041-5.
-
2001: Gumina R J; Jahangir A; Gross G J; Terzic A
Cardioprotection: emerging pharmacotherapy.
Expert opinion on pharmacotherapy 2001;2(5):739-52.
-
2001: Nithipatikom K; DiCamelli R F; Kohler S; Gumina R J; Falck J R; Campbell W B; Gross G J
Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Analytical biochemistry 2001;292(1):115-24.
-
2001: Fryer R M; Hsu A K; Gross G J
ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection.
Basic research in cardiology 2001;96(2):136-42.
-
2001: Fryer R M; Hsu A K; Gross G J
Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts.
Journal of molecular and cellular cardiology 2001;33(4):831-4.
-
2001: Fryer R M; Wang Y; Hsu A K; Gross G J
Essential activation of PKC-delta in opioid-initiated cardioprotection.
American journal of physiology. Heart and circulatory physiology 2001;280(3):H1346-53.
-
2001: Patel H H; Hsu A; Gross G J
Cardioprotection is strain dependent in rat in response to whole body hyperthermia.
American journal of physiology. Heart and circulatory physiology 2001;280(3):H1208-14.
-
2001: Schultz J E; Gross G J
Opioids and cardioprotection.
Pharmacology & therapeutics 2001;89(2):123-37.
-
2001: Baker J E; Contney S J; Singh R; Kalyanaraman B; Gross G J; Bosnjak Z J
Nitric oxide activates the sarcolemmal K(ATP) channel in normoxic and chronically hypoxic hearts by a cyclic GMP-dependent mechanism.
Journal of molecular and cellular cardiology 2001;33(2):331-41.
-
2001: Fryer R M; Pratt P F; Hsu A K; Gross G J
Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection.
The Journal of pharmacology and experimental therapeutics 2001;296(2):642-9.
-
2000: Eells J T; Henry M M; Gross G J; Baker J E
Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics?
Circulation research 2000;87(10):915-21.
-
2000: Gumina R J; Auchampach J; Wang R; Buerger E; Eickmeier C; Moore J; Daemmgen J; Gross G J
Na(+)/H(+) exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes.
American journal of physiology. Heart and circulatory physiology 2000;279(4):H1563-70.
-
2000: Gross G J
The role of mitochondrial KATP channels in cardioprotection.
Basic research in cardiology 2000;95(4):280-4.
-
2000: Fryer R M; Hsu A K; Nagase H; Gross G J
Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
The Journal of pharmacology and experimental therapeutics 2000;294(2):451-7.
-
2000: Toller W G; Gross E R; Kersten J R; Pagel P S; Gross G J; Warltier D C
Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: mechanism of desflurane-induced cardioprotection.
Anesthesiology 2000;92(6):1731-9.
-
2000: Gumina R J; Beier N; Schelling P; Gross G J
Inhibitors of ischemic preconditioning do not attenuate Na+/H+ exchange inhibitor mediated cardioprotection.
Journal of cardiovascular pharmacology 2000;35(6):949-53.
-
2000: Gumina R J; Daemmgen J; Gross G J
Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
European journal of pharmacology 2000;396(2-3):119-24.
-
2000: Baker J E; Konorev E A; Gross G J; Chilian W M; Jacob H J
Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection?
American journal of physiology. Heart and circulatory physiology 2000;278(4):H1395-400.
-
2000: Fryer R M; Eells J T; Hsu A K; Henry M M; Gross G J
Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function.
American journal of physiology. Heart and circulatory physiology 2000;278(1):H305-12.
-
1999: Gumina R J; Buerger E; Eickmeier C; Moore J; Daemmgen J; Gross G J
Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs.
Circulation 1999;100(25):2519-26; discussion 2469-72.
-
1999: Chilian W M; Gross G J
Prologue: ischemic preconditioning in cardiac vascular muscle.
The American journal of physiology 1999;277(6 Pt 2):H2416-7.
-
1999: Gross G J; Kersten J R; Warltier D C
Mechanisms of postischemic contractile dysfunction.
The Annals of thoracic surgery 1999;68(5):1898-904.
-
1999: Gumina R J; Gross G J
If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition.
Journal of thrombosis and thrombolysis 1999;8(1):39-44.
-
1999: Gross G J; Fryer R M
Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning.
Circulation research 1999;84(9):973-9.
-
1999: Fryer R M; Hsu A K; Eells J T; Nagase H; Gross G J
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels.
Circulation research 1999;84(7):846-51.
-
1999: Fryer R M; Schultz J E; Hsu A K; Gross G J
Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts.
The American journal of physiology 1999;276(4 Pt 2):H1229-35.
-
1999: Baker J E; Holman P; Gross G J
Preconditioning in immature rabbit hearts: role of KATP channels.
Circulation 1999;99(9):1249-54.
-
1998: Fryer R M; Schultz J E; Hsu A K; Gross G J
Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts.
The American journal of physiology 1998;275(6 Pt 2):H2009-15.
-
1998: Auchampach J A; Pieper G M; Cavero I; Gross G J
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Basic research in cardiology 1998;93(5):361-71.
-
1998: Gross G J
Recombinant cardiac ATP-sensitive potassium channels and cardioprotection.
Circulation 1998;98(15):1479-80.
-
1998: Schultz J E; Kwok W M; Hsu A K; Gross G J
Terikalant, an inward-rectifier potassium channel blocker, does not abolish the cardioprotection induced by ischemic preconditioning in the rat.
Journal of molecular and cellular cardiology 1998;30(9):1817-25.
-
1998: Schultz J E; Hsu A K; Barbieri J T; Li P L; Gross G J
Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart.
The American journal of physiology 1998;275(2 Pt 2):H495-500.
-
1998: Elliott G T; Mei D A; Gross G J
Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
Journal of cardiovascular pharmacology 1998;32(1):49-56.
-
1998: Gumina R J; Mizumura T; Beier N; Schelling P; Schultz J J; Gross G J
A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion.
The Journal of pharmacology and experimental therapeutics 1998;286(1):175-83.
-
1998: Mei D A; Nithipatikom K; Lasley R D; Gross G J
Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
Journal of molecular and cellular cardiology 1998;30(6):1225-36.
-
1998: Schultz J E; Hsu A K; Gross G J
Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors.
Circulation 1998;97(13):1282-9.
-
1998: Schultz J el-J; Hsu A K; Nagase H; Gross G J
TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels.
The American journal of physiology 1998;274(3 Pt 2):H909-14.
-
1998: Kersten J R; Gross G J; Pagel P S; Warltier D C
Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection.
Anesthesiology 1998;88(2):495-513.
-
1997: Kersten J R; Schmeling T J; Pagel P S; Gross G J; Warltier D C
Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.
Anesthesiology 1997;87(2):361-70.
-
1997: Schultz J J; Hsu A K; Gross G J
Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart.
Journal of molecular and cellular cardiology 1997;29(8):2187-95.
-
1997: Schultz J E; Yao Z; Cavero I; Gross G J
Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart.
The American journal of physiology 1997;272(6 Pt 2):H2607-15.
-
1997: Schultz J J; Hsu A K; Gross G J
Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart.
Journal of molecular and cellular cardiology 1997;29(5):1355-62.
-
1997: Kersten J R; Orth K G; Pagel P S; Mei D A; Gross G J; Warltier D C
Role of adenosine in isoflurane-induced cardioprotection.
Anesthesiology 1997;86(5):1128-39.
-
1997: Schultz J E; Qian Y Z; Gross G J; Kukreja R C
The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart.
Journal of molecular and cellular cardiology 1997;29(3):1055-60.
-
1997: Baker J E; Curry B D; Olinger G N; Gross G J
Increased tolerance of the chronically hypoxic immature heart to ischemia. Contribution of the KATP channel.
Circulation 1997;95(5):1278-85.
-
1997: Baker J E; Contney S J; Gross G J; Bosnjak Z J
KATP channel activation in a rabbit model of chronic myocardial hypoxia.
Journal of molecular and cellular cardiology 1997;29(2):845-8.
-
1997: Gross G J; Mei D A; Sleph P G; Grover G J
Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
The Journal of pharmacology and experimental therapeutics 1997;280(2):533-40.
-
1997: Yao Z; Mizumura T; Mei D A; Gross G J
KATP channels and memory of ischemic preconditioning in dogs: synergism between adenosine and KATP channels.
The American journal of physiology 1997;272(1 Pt 2):H334-42.
-
1996: Mei D A; Elliott G T; Gross G J
KATP channels mediate late preconditioning against infarction produced by monophosphoryl lipid A.
The American journal of physiology 1996;271(6 Pt 2):H2723-9.
-
1996: Gumina R J; el Schultz J; Yao Z; Kenny D; Warltier D C; Newman P J; Gross G J
Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury.
Circulation 1996;94(12):3327-33.
-
1996: Stowe D F; Graf B M; Fujita S; Gross G J
One-day cold perfusion of bimakalim and butanedione monoxime restores ex situ cardiac function.
The American journal of physiology 1996;271(5 Pt 2):H1884-92.
-
1996: Kersten J R; Schmeling T J; Hettrick D A; Pagel P S; Gross G J; Warltier D C
Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
Anesthesiology 1996;85(4):794-807; discussion 27A.
-
1996: Mizumura T; Auchampach J A; Linden J; Bruns R F; Gross G J
PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs.
Circulation research 1996;79(3):415-23.
-
1996: Mizumura T; Nithipatikom K; Gross G J
Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs.
Cardiovascular research 1996;32(2):274-85.
-
1996: Kersten J R; Lowe D; Hettrick D A; Pagel P S; Gross G J; Warltier D C
Glyburide, a KATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium.
Anesthesia and analgesia 1996;83(1):27-33.
-
1996: Mei D A; Gross G J; Nithipatikom K
Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector.
Analytical biochemistry 1996;238(1):34-9.
-
1996: Schultz J E; Hsu A K; Gross G J
Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart.
Circulation research 1996;78(6):1100-4.
-
1996: Gross G J; Mei D A; Schultz J J; Mizumura T
Criteria for a mediator or effector of myocardial preconditioning: do KATP channels meet the requirements?
Basic research in cardiology 1996;91(1):31-4.
-
1995: Mizumura T; Nithipatikom K; Gross G J
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Circulation 1995;92(5):1236-45.
-
1995: Yao Z; Elliott G T; Gross G J
Monophosphoryl lipid A preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs.
Pharmacology 1995;51(3):152-9.
-
1995: Mei D A; Gross G J
Evidence for the involvement of the ATP-sensitive potassium channel in a novel model of hypoxic preconditioning in dogs.
Cardiovascular research 1995;30(2):222-30.
-
1995: Gross G J
Do ATP-sensitive potassium channels play a role in myocardial stunning?
Basic research in cardiology 1995;90(4):266-8.
-
1995: Schultz J E; Rose E; Yao Z; Gross G J
Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts.
The American journal of physiology 1995;268(5 Pt 2):H2157-61.
-
1995: Mizumura T; Nithipatikom K; Gross G J
Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Cardiovascular research 1995;29(4):482-9.
-
1995: Gross G J
ATP-sensitive potassium channels and myocardial preconditioning.
Basic research in cardiology 1995;90(2):85-8.
-
1994: Nithipatikom K; Mizumura T; Gross G J
Determination of plasma adenosine by high-performance liquid chromatography with column switching and fluorometric detection.
Analytical biochemistry 1994;223(2):280-4.
-
1994: Yao Z; Gross G J
Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs.
The American journal of physiology 1994;267(5 Pt 2):H1888-94.
-
1994: Auchampach J A; Maruyama M; Gross G J
Cardioprotective actions of potassium channel openers.
European heart journal 1994;15 Suppl C():89-94.
-
1994: Yao Z; Foster P A; Gross G J
Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation.
Circulatory shock 1994;43(3):107-14.
-
1994: Gross G J; Yao Z; Pieper G M; Auchampach J A
The ATP-regulated potassium channel in ischemia-reperfusion injury.
Annals of the New York Academy of Sciences 1994;723():71-81.
-
1994: Pieper G M; Clarke G A; Gross G J
Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
The Journal of pharmacology and experimental therapeutics 1994;269(2):451-6.
-
1994: Yao Z; Gross G J
Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
Circulation 1994;89(4):1769-75.
-
1994: Auchampach J A; Gross G J
Reduction in myocardial infarct size by the new potassium channel opener bimakalim.
Journal of cardiovascular pharmacology 1994;23(4):554-61.
-
1994: Yao Z; Gross G J
A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.
Circulation 1994;89(3):1229-36.
-
1994: Yao Z; Gross G J
The ATP-dependent potassium channel: an endogenous cardioprotective mechanism.
Journal of cardiovascular pharmacology 1994;24 Suppl 4():S28-34.
-
1993: Yao Z; Rasmussen J L; Hirt J L; Mei D A; Pieper G M; Gross G J
Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs.
Journal of cardiovascular pharmacology 1993;22(4):653-63.
-
1993: Auchampach J A; Gross G J
Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
European heart journal 1993;14 Suppl B():10-5.
-
1993: Yao Z; Gross G J
Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
Circulation 1993;88(1):235-44.
-
1993: Boban M; Stowe D F; Gross G J; Pieper G M; Kampine J P; Bosnjak Z J
Potassium channel openers attenuate atrioventricular block by bupivacaine in isolated hearts.
Anesthesia and analgesia 1993;76(6):1259-65.
-
1993: Yao Z; Gross G J
Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs.
The American journal of physiology 1993;264(6 Pt 2):H2221-5.
-
1993: Auchampach J A; Gross G J
Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs.
The American journal of physiology 1993;264(5 Pt 2):H1327-36.
-
1993: Yao Z; Auchampach J A; Pieper G M; Gross G J
Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog.
Cardiovascular research 1993;27(5):832-8.
-
1993: Pieper G M; Langenstroer P; Gross G J
Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rat.
Molecular and cellular biochemistry 1993;122(2):139-45.
-
1993: Warltier D C; Auchampach J A; Gross G J
Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation.
Journal of cardiac surgery 1993;8(2 Suppl):279-83.
-
1993: Yao Z; Cavero I; Gross G J
Activation of cardiac KATP channels: an endogenous protective mechanism during repetitive ischemia.
The American journal of physiology 1993;264(2 Pt 2):H495-504.
-
1992: Gross G J; O'Rourke S T; Pelc L R; Warltier D C
Myocardial and endothelial dysfunction after multiple, brief coronary occlusions: role of oxygen radicals.
The American journal of physiology 1992;263(6 Pt 2):H1703-9.
-
1992: Auchampach J A; Grover G J; Gross G J
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
Cardiovascular research 1992;26(11):1054-62.
-
1992: Gross G J; Auchampach J A
Role of ATP dependent potassium channels in myocardial ischaemia.
Cardiovascular research 1992;26(11):1011-6.
-
1992: Auchampach J A; Maruyama M; Cavero I; Gross G J
Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning.
Circulation 1992;86(1):311-9.
-
1992: Pieper G M; Gross G J
Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1992;6(3):225-32.
-
1992: Pieper G M; Gross G J
EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes.
Immunopharmacology 1992;23(3):191-7.
-
1992: Gross G J; Pieper G M
Beneficial actions of amlodipine in the multiple-stunned canine myocardium.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1992;6(1):67-75.
-
1992: Gross G J; Auchampach J A
Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
Circulation research 1992;70(2):223-33.
-
1992: Gross G J; Auchampach J A; Maruyama M; Warltier D C; Pieper G M
Cardioprotective effects of nicorandil.
Journal of cardiovascular pharmacology 1992;20 Suppl 3():S22-8.
-
1992: Auchampach J A; Cavero I; Gross G J
Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
Journal of cardiovascular pharmacology 1992;20(5):765-71.
-
1991: Auchampach J A; Maruyama M; Cavero I; Gross G J
The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.
The Journal of pharmacology and experimental therapeutics 1991;259(3):961-7.
-
1991: Buljubasic N; Marijic J; Stowe D F; Gross G J; Kampine J P; Bosnjak Z J
Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression.
Journal of cardiovascular pharmacology 1991;18(4):594-604.
-
1991: Pelc L R; Gross G J; Warltier D C
Mechanism of coronary vasodilation produced by bradykinin.
Circulation 1991;83(6):2048-56.
-
1991: Maruyama M; Pieper G M; Kalyanaraman B; Hallaway P E; Hedlund B E; Gross G J
Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs.
Journal of cardiovascular pharmacology 1991;17(1):166-75.
-
1990: Maruyama M; Farber N E; Vercellotti G M; Jacob H S; Gross G J
Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
American heart journal 1990;120(3):510-20.
-
1990: Pieper G M; Gross G J
Augmented vascular relaxation to KT-362 in diabetic rat aorta: comparison to diltiazem.
Journal of cardiovascular pharmacology 1990;16(3):394-400.
-
1990: Pelc L R; Garancis J C; Gross G J; Warltier D C
Alteration of endothelium-dependent distribution of myocardial blood flow after coronary occlusion and reperfusion.
Circulation 1990;81(6):1928-37.
-
1990: Farber N E; Gross G J
Prostaglandin redirection by thromboxane synthetase inhibition. Attenuation of myocardial stunning in canine heart.
Circulation 1990;81(1):369-80.
-
1990: Pieper G M; Gross G J
Differential response of postischemic diabetic myocardium to a thromboxane-mimetic.
Eicosanoids 1990;3(3):127-33.
-
1990: Pieper G M; Gross G J; Kalyanaraman B
An ESR study of the nitroxide radical of pentastarch-conjugated deferoxamine.
Free radical biology & medicine 1990;9(3):211-8.
-
1989: Gross G J; Farber N E; Pieper G M
Effects of amlodipine on myocardial ischemia-reperfusion injury in dogs.
The American journal of cardiology 1989;64(17):94I-100I.
-
1989: Gross G J; Farber N E; Pieper G M
Effect of amlodipine on myocardial functional and metabolic recovery following coronary occlusion and reperfusion in dogs.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1989;3(4):535-43.
-
1989: Farber N E; Gross G J
Prostaglandin E1 attenuates postischemic contractile dysfunction after brief coronary occlusion and reperfusion.
American heart journal 1989;118(1):17-24.
-
1989: Farber N E; Gross G J
Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem.
Journal of cardiovascular pharmacology 1989;14(1):66-72.
-
1989: Pieper G M; Gross G J
Diabetes alters postischemic response to a prostacyclin mimetic.
The American journal of physiology 1989;256(5 Pt 2):H1353-60.
-
1989: al-Wathiqui M H; Farber N; Pelc L; Gross G J; Brooks H L; Warltier D C
Improvement in functional recovery of stunned canine myocardium by long-term pretreatment with oral propranolol.
American heart journal 1989;117(4):791-8.
-
1989: Pelc L R; Farber N E; Warltier D C; Gross G J
Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs.
Journal of cardiovascular pharmacology 1989;13(4):586-93.
-
1989: Eskinder H; Hillard C J; Wilke R A; Gross G J
Effect of KT-362, a putative intracellular calcium antagonist, on norepinephrine-induced contractions and inositol monophosphate accumulation in canine femoral artery.
Journal of cardiovascular pharmacology 1989;13(3):502-7.
-
1989: Farber N E; Gross G J
Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium.
The Journal of pharmacology and experimental therapeutics 1989;248(1):39-43.
-
1989: Pieper G M; Gross G J
Diabetes enhances vasoreactivity to calcium entry blockers.
Artery 1989;16(5):263-71.
-
1989: Gross G J; Pieper G M
Effect of cyclooxygenase blockade on the beneficial actions of nicorandil in the stunned myocardium of dogs.
Pharmacology 1989;38(6):341-51.
-
1989: Pieper G M; Gross G J
Protective effect of nicorandil on postischemic function and tissue adenine nucleotides following a brief period of low-flow global ischemia in the isolated perfused rat heart.
Pharmacology 1989;38(4):205-13.
-
1989: Pieper G M; Gross G J
Selective impairment of endothelium-dependent relaxation by oxygen-derived free radicals: distinction between receptor versus nonreceptor mediators.
Blood vessels 1989;26(1):44-7.
-
1988: al-Wathiqui M H; Hartman J C; Brooks H L; Gross G J; Warltier D C
Cyclical carotid artery flow reduction in conscious dogs: effect of a new thromboxane receptor antagonist.
American heart journal 1988;116(6 Pt 1):1482-7.
-
1988: Eskinder H; Hillard C J; Olinger G N; Christensen C W; Baker J E; Warltier D C; Gross G J
Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
The Journal of pharmacology and experimental therapeutics 1988;247(3):941-8.
-
1988: Pieper G M; Gross G J
Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta.
The American journal of physiology 1988;255(4 Pt 2):H825-33.
-
1988: Wynsen J C; Preuss K C; Gross G J; Brooks H L; Warltier D C
Steroid-induced enhancement of functional recovery of postischemic, reperfused myocardium in conscious dogs.
American heart journal 1988;116(4):915-25.
-
1988: Farber N E; Pieper G M; Gross G J
Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosis.
American heart journal 1988;116(2 Pt 1):407-20.
-
1988: Farber N E; Pieper G M; Gross G J
Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
Circulation 1988;78(2):450-61.
-
1988: Farber N E; Vercellotti G M; Jacob H S; Pieper G M; Gross G J
Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart.
Circulation research 1988;63(2):351-60.
-
1988: Pieper G M; Farber N E; Gross G J
Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.
Prostaglandins, leukotrienes, and essential fatty acids 1988;33(1):13-22.
-
1988: Pelc L R; Gross G J; Kampine J P; Warltier D C
Mechanisms of enhanced canine subendocardial perfusion. A comparison of adenosine triphosphate and sodium nitroprusside.
Anesthesia and analgesia 1988;67(6):514-20.
-
1988: Pelc L R; Daemmgen J W; Gross G J; Warltier D C
Muscarinic receptor subtypes mediating myocardial blood flow redistribution.
Journal of cardiovascular pharmacology 1988;11(4):424-31.
-
1988: Farber N E; Pieper G M; Thomas J P; Gross G J
Beneficial effects of iloprost in the stunned canine myocardium.
Circulation research 1988;62(2):204-15.
-
1988: Eskinder H; Gross G J
8-Bromo cyclic GMP mimics the actions of nitroglycerin in modulating responses produced by full and partial alpha-adrenoceptor agonists in canine saphenous vein.
European heart journal 1988;9 Suppl A():11-5.
-
1988: Al-Wathiqui M H; Shimshak T M; Brooks H L; Preuss K C; Wynsen J C; Gross G J; Warltier D C
Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Pharmacology 1988;36(4):217-27.
-
1988: Hartman J C; Al-Wathiqui M H; Brooks H L; Gross G J; Warltier D C
Hemodynamic and electrocardiographic actions of the new intracellular calcium antagonist, KT-362, in the conscious dog.
Pharmacology 1988;37(6):376-84.
-
1988: Warltier D C; Gross G J; Brooks H L; Preuss K C
Improvement of postischemic, contractile function by the calcium channel blocking agent nitrendipine in conscious dogs.
Journal of cardiovascular pharmacology 1988;12 Suppl 4():S120-4.
-
1987: Gross G J; Daemmgen J W
Effects of bradycardic agents on ischaemic myocardium and perfusion in anesthetized dogs.
European heart journal 1987;8 Suppl L():69-74.
-
1987: Riley D C; Gross G J; Kampine J P; Warltier D C
Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs.
Anesthesiology 1987;67(5):707-16.
-
1987: Farber N E; Pieper G M; Gross G J
Regional differences in postischemic recovery in the stunned canine myocardium.
American heart journal 1987;114(5):1086-95.
-
1987: Gross G J; Warltier D C; Hardman H F
Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
Journal of cardiovascular pharmacology 1987;10(5):535-42.
-
1987: Preuss K C; Gross G J; Brooks H L; Warltier D C
Time course of recovery of "stunned" myocardium following variable periods of ischemia in conscious and anesthetized dogs.
American heart journal 1987;114(4 Pt 1):696-703.
-
1987: Pieper G M; Gross G J
Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate.
Circulation 1987;76(4):916-28.
-
1987: Wynsen J C; Gross G J; Brooks H L; Warltier D C
Changes in adrenergic pressor responses by calcium channel modulation in conscious dogs.
The American journal of physiology 1987;253(3 Pt 2):H531-9.
-
1987: Wynsen J C; Gross G J; Brooks H L; Warltier D C
Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs.
The Journal of pharmacology and experimental therapeutics 1987;241(3):846-54.
-
1987: Wynsen J C; Shimshak T M; Preuss K C; Gross G J; Brooks H L; Warltier D C
Stimulation of myocardium during reperfusion injury by a new inotrope-vasodilator agent, MCI-154.
Fundamental & clinical pharmacology 1987;1(5):335-45.
-
1987: Eskinder H; Gross G J
Sensitivity of alpha-adrenoceptor agonists to the calcium channel activator, Bay K 8644, in canine saphenous vein.
Pharmacology 1987;35(5):272-8.
-
1987: Gross G J; Pieper G M; Warltier D C
Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium.
Journal of cardiovascular pharmacology 1987;10 Suppl 8():S76-84.
-
1986: Shimshak T M; Preuss K C; Gross G J; Brooks H L; Warltier D C
Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent.
Cardiovascular research 1986;20(8):621-6.
-
1986: Gross G J; Farber N E; Hardman H F; Warltier D C
Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs.
The American journal of physiology 1986;250(3 Pt 2):H372-7.
-
1985: Preuss K C; Gross G J; Brooks H L; Warltier D C
Slow channel calcium activators, a new group of pharmacological agents.
Life sciences 1985;37(14):1271-8.
-
1985: Preuss K C; Gross G J; Brooks H L; Warltier D C
Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog.
Journal of cardiovascular pharmacology 1985;7(4):709-14.
-
1985: Preuss K C; Brooks H L; Gross G J; Warltier D C
Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs.
Basic research in cardiology 1985;80(3):326-32.
Sign-in to see more
